Patents by Inventor Huiying Wang

Huiying Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240111536
    Abstract: The present disclosure provides a data processing apparatus and related products. The products include a control module including an instruction caching unit, an instruction processing unit, and a storage queue unit. The instruction caching unit is configured to store computation instructions associated with an artificial neural network operation; the instruction processing unit is configured to parse the computation instructions to obtain a plurality of operation instructions; and the storage queue unit is configured to store an instruction queue, where the instruction queue includes a plurality of operation instructions or computation instructions to be executed in the sequence of the queue. By adopting the above-mentioned method, the present disclosure can improve the operation efficiency of related products when performing operations of a neural network model.
    Type: Application
    Filed: December 7, 2023
    Publication date: April 4, 2024
    Applicant: CAMBRICON TECHNOLOGIES CORPORATION LIMITED
    Inventors: Shaoli Liu, Bingrui Wang, Xiaoyong ZHOU, Yimin ZHUANG, Huiying LAN, Jun LIANG, Hongbo ZENG
  • Publication number: 20240095501
    Abstract: A multi-modal adaptive fusion deep clustering model based on an auto-encoder includes an encoder structure, a multi-modal adaptive fusion layer, a decoder structure and a deep embedding clustering layer. The encoder is configured to enable a dataset to be respectively subjected to three types of nonlinear mappings of the auto-encoder, a convolutional auto-encoder and a convolutional variational auto-encoder to obtain potential features, respectively. The multi-modal adaptive feature fusion layer is configured to fuse the potential features into a common subspace in an adaptive spatial feature fusion mode to obtain a fused feature. The decoder is configured to decode the fused feature by using a structure symmetrical to the encoder to obtain a decoded reconstructed dataset. The deep embedding clustering layer is configured to cluster the fused feature Z and obtain a final accuracy ACC by comparing a clustering result with a true label.
    Type: Application
    Filed: November 17, 2021
    Publication date: March 21, 2024
    Applicant: ZHEJIANG NORMAL UNIVERSITY
    Inventors: Xinzhong ZHU, Huiying XU, Shihao DONG, Xifeng GUO, Xia WANG, Lintong JIN, Jianmin ZHAO
  • Publication number: 20240093142
    Abstract: The present invention relates to the fields of microorgan-isms, feed, food and ecological restoration, in particular to a strain for degrading deoxynivalenol (DON) and the use thereof. The strain has the deposit number CCTCC No. M 2020565. The strain can grow by means of taking the toxic compound DON as a sole carbon source, and convert the DON into chemical components for itself. The reaction process is irreversible, the reaction conditions are moderate, and secondary pollu-tion cannot be caused. The strain provided in the present invention can be used for preparing a biological detoxification preparation for DON. The strain provided in the present invention can be used for degrading DON in feed and food raw materials, primary processing products, deep processing products and related processing byproducts. The strain provided in the present invention can be applied to various ecosystems such as soil or bodies of water polluted by DON to achieve the purposes of DON degradation and ecological restoration.
    Type: Application
    Filed: November 11, 2021
    Publication date: March 21, 2024
    Inventors: Huiying LUO, Honghai ZHANG, Bin YAO, Huoqing HUANG, Yaru WANG, Yingguo BAI, Xiaoyun SU, Yuan WANG, Tao TU, Jie ZHANG, Huimin YU, Xing QIN, Xiaolu WANG
  • Publication number: 20230414681
    Abstract: Bifidobacterium longum strain NCIMB 41676 is useful for improving or sustaining vitality and/or reducing mental fatigue in stressful situations.
    Type: Application
    Filed: August 24, 2023
    Publication date: December 28, 2023
    Applicant: PrecisionBiotics Group Limited
    Inventors: Eileen Frances MURPHY, Paul ENCK, Christoph BRAUN, Huiying WANG
  • Patent number: 11771723
    Abstract: Bifidobacterium longum strain NCIMB 41676 is useful for improving or sustaining vitality and/or reducing mental fatigue in stressful situations.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: October 3, 2023
    Assignee: PrecisionBiotics Group Limited
    Inventors: Eileen Frances Murphy, Paul Enck, Christoph Braun, Huiying Wang
  • Patent number: 10385903
    Abstract: A metric self-tapping locking screw comprises a screw head which is connected to a thread locking body by a screw rod. The thread locking body and the self-tapping tip are provided with a screw thread on the surface. The self-tapping tip is arranged at the root of the thread locking body; the screw thread adopts the basic structure of the standard ordinary triangular thread. The flank angle back to the fastened surface is 15-20° and the flank angle of the screw thread facing the fastened surface is 30°. The metric self-tapping locking screw in the Invention make the installed parts to be fastened have higher axial clamping force and static loosing moment, which solves the attenuation problem of axial clamping force and static moment of fastened parts.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: August 20, 2019
    Assignee: Essence Fastening System (Shanghai) Co., Ltd.
    Inventors: Qinfeng Yi, Huiying Wang, Xin'an Li
  • Publication number: 20180223889
    Abstract: A metric self-tapping locking screw comprises a screw head which is connected to a thread locking body by a screw rod. The thread locking body and the self-tapping tip are provided with a screw thread on the surface. The self-tapping tip is arranged at the root of the thread locking body; the screw thread adopts the basic structure of the standard ordinary triangular thread. The flank angle back to the fastened surface is 15-20° and the flank angle of the screw thread facing the fastened surface is 30°. The metric self-tapping locking screw in the Invention make the installed parts to be fastened have higher axial clamping force and static loosing moment, which solves the attenuation problem of axial clamping force and static moment of fastened parts.
    Type: Application
    Filed: May 5, 2017
    Publication date: August 9, 2018
    Inventors: Qinfeng Yi, Huiying Wang, Xin'an Li
  • Patent number: 8906603
    Abstract: Compositions, methods and devices for the detection of anti-lipoidal antibodies and the diagnosis of disease, for example, syphilis, are described. In particular, oxidized cardiolipins, which may be conjugated with a variety of attachment molecules, such as BSA, KLH, biotin, synthetic protein MAPS, IgY, streptavidin, or avidin, are described. Such oxidized cardiolipin, alone or complexed with one or more attachment molecules, are useful to detect anti-lipoidal antibodies in subjects, for example, when used in lateral flow devices. Lateral flow devices are described that permit the detection of anti-lipoidal antibodies and that permit the co-detection of nontreponemal and treponemal antibodies in biological samples.
    Type: Grant
    Filed: February 14, 2011
    Date of Patent: December 9, 2014
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
    Inventors: Arnold R. Castro, Huiying Wang
  • Publication number: 20140242407
    Abstract: An in-situ compressed specimen of copper interconnection micro column, which is a circular metal column formed in a PDMS hole, includes: a specimen part and a fixed end part for fixing the specimen; wherein the fixed end part is a circular or square plate structure, the specimen part is an upper part of the fixed end part; a main body of the present invention is of micron order, a forced direction of the specimen is consistent with a growth direction of the metal column. A method of electroplating copper column by adopting PDMS as template substrate is applied to overcome a problem that TSV is corrosive to the copper column during a silicon etching process so as to affect a mechanical property accuracy test, the method is advanced in shortening test process period, achieving good reproducibility and high yield.
    Type: Application
    Filed: March 25, 2013
    Publication date: August 28, 2014
    Applicant: Shanghai Jiao Tong University
    Inventors: Hong Wang, Zhaoyu Wang, Ping Cheng, Guifu Ding, Ting Gu, Huiying Wang, Congchun Zhang
  • Publication number: 20120064390
    Abstract: Electrolytes of lithium ion batteries of the present disclosure comprise: a lithium salt, a non-aqueous solvent, and an additive. The additive further comprises a first and second compound. The first compound is a 4 X1, 5 R1 [1,3]dioxolan-2-one, wherein X1 is selected from the group consisting of: F, Cl, and Br and R1 is selected from the group consisting of hydrogen and linear alkyl compounds having between 1 and 3 carbon atoms. The second compound has a molecular formula of: F(CF2CF2)x—CH2CH2—(CH2CH2O)yH, wherein x is any integer ranging from 1 to 7, and y is any integer ranging from 1 to 15.
    Type: Application
    Filed: September 9, 2011
    Publication date: March 15, 2012
    Inventors: Huiying Wang, Guishu Zhou
  • Publication number: 20110136143
    Abstract: Compositions, methods and devices for the detection of anti-lipoidal antibodies and the diagnosis of disease, for example, syphilis, are described. In particular, oxidized cardiolipins, which may be conjugated with a variety of attachment molecules, such as BSA, KLH, biotin, synthetic protein MAPS, IgY, streptavidin, or avidin, are described. Such oxidized cardiolipin, alone or complexed with one or more attachment molecules, are useful to detect anti-lipoidal antibodies in subjects, for example, when used in lateral flow devices. Lateral flow devices are described that permit the detection of anti-lipoidal antibodies and that permit the co-detection of nontreponemal and treponemal antibodies in biological samples.
    Type: Application
    Filed: February 14, 2011
    Publication date: June 9, 2011
    Inventors: Arnold R. Castro, Huiying Wang
  • Patent number: 7888043
    Abstract: Compositions, methods and devices for the detection of anti-lipoidal antibodies and the diagnosis of disease, for example, syphilis, are described. In particular, oxidized cardiolipins, which may be conjugated with a variety of attachment molecules, such as BSA, KLH, biotin, synthetic protein MAPS, IgY, streptavidin, or avidin, are described. Such oxidized cardiolipin, alone or complexed with one or more attachment molecules, are useful to detect anti-lipoidal antibodies in subjects, for example, when used in lateral flow devices. Lateral flow devices are described that permit the detection of anti-lipoidal antibodies and that permit the co-detection of nontreponemal and treponemal antibodies in biological samples.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: February 15, 2011
    Assignee: The United States of America as represented by the Department of Health and Human Services, Centers for Disease Control and Prevention
    Inventors: Arnold R. Castro, Huiying Wang
  • Publication number: 20090253219
    Abstract: Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog.
    Type: Application
    Filed: March 2, 2009
    Publication date: October 8, 2009
    Inventors: Jeffrey S. Bauer, Timothy P. Hyatt, Huiying Wang, Robert L. Buck
  • Patent number: 7517699
    Abstract: Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog.
    Type: Grant
    Filed: February 21, 2006
    Date of Patent: April 14, 2009
    Assignee: Quantrx Biomedical Corporation
    Inventors: Jeffrey S. Bauer, Timothy P. Hyatt, Huiying Wang, Robert L. Buck
  • Publication number: 20080311597
    Abstract: Compositions, methods and devices for the detection of anti-lipoidal antibodies and the diagnosis of disease, for example, syphilis, are described. In particular, oxidized cardiolipins, which may be conjugated with a variety of attachment molecules, such as BSA, KLH, biotin, synthetic protein MAPS, IgY, streptavidin, or avidin, are described. Such oxidized cardiolipin, alone or complexed with one or more attachment molecules, are useful to detect anti-lipoidal antibodies in subjects, for example, when used in lateral flow devices. Lateral flow devices are described that permit the detection of anti-lipoidal antibodies and that permit the co-detection of nontreponemal and treponemal antibodies in biological samples.
    Type: Application
    Filed: November 17, 2006
    Publication date: December 18, 2008
    Inventors: Arnold R. Castro, Huiying Wang
  • Publication number: 20060141639
    Abstract: Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog.
    Type: Application
    Filed: February 21, 2006
    Publication date: June 29, 2006
    Inventors: Jeffrey Bauer, Timothy Hyatt, Huiying Wang, Robert Buck
  • Patent number: 6699722
    Abstract: Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: March 2, 2004
    Assignee: A-Fem Medical Corporation
    Inventors: Jeffrey S. Bauer, Timothy P. Hyatt, Huiying Wang
  • Publication number: 20020142291
    Abstract: Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog.
    Type: Application
    Filed: April 13, 2001
    Publication date: October 3, 2002
    Inventors: Jeffrey S. Bauer, Timothy P. Hyatt, Huiying Wang
  • Patent number: 6306665
    Abstract: Microporous solid phase materials that are suitable for lateral flow and other assays for detecting the presence of analytes in test samples, that are stable under variations in humidity and, even after storage for extended periods of time, can form stable covalent bonds with molecules containing a free primary or secondary amine group or sulfhydryl group are described. The invention further concerns chemically derivatized solid phase materials, and conjugates comprising such materials. Examples of lateral flow devices for the quantitative or semi-quantitative determination of an analyte in a biological sample are described.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: October 23, 2001
    Assignee: A-Fem Medical Corporation
    Inventors: Robert Lee Buck, Huiying Wang, Timothy Patrick Hyatt, Paul Andrew Mueggler